The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients

2020 ◽  
Vol 38 (6) ◽  
pp. 602.e1-602.e10 ◽  
Author(s):  
Koichiro Ogihara ◽  
Eiji Kikuchi ◽  
Keisuke Shigeta ◽  
Takashi Okabe ◽  
Seiya Hattori ◽  
...  
2014 ◽  
Vol 12 (2) ◽  
pp. e69-e70 ◽  
Author(s):  
Sevket Balta ◽  
Sait Demırkol ◽  
Ugur Kucuk ◽  
Mustafa Cakar ◽  
Murat Unlu

Sign in / Sign up

Export Citation Format

Share Document